Clinical Trial Update: A Study of RO5458640 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Hoffmann-La Roche completed a Phase 1 study of RO5458640 in patients with advanced solid tumors (NCT01383733). The trial status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• RO5458640

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED